Head to Head Survey: Charlie’s (CHUC) & Its Peers

Charlie’s (OTCMKTS:CHUCGet Rating) is one of 59 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its rivals? We will compare Charlie’s to related businesses based on the strength of its risk, institutional ownership, dividends, valuation, analyst recommendations, earnings and profitability.

Institutional and Insider Ownership

12.3% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 50.5% of Charlie’s shares are held by company insiders. Comparatively, 23.9% of shares of all “Medicinals & botanicals” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Charlie’s and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Charlie’s $26.42 million -$1.59 million -9.70
Charlie’s Competitors $277.16 million -$110.28 million -5.04

Charlie’s’ rivals have higher revenue, but lower earnings than Charlie’s. Charlie’s is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Charlie’s has a beta of 4.62, suggesting that its stock price is 362% more volatile than the S&P 500. Comparatively, Charlie’s’ rivals have a beta of 1.16, suggesting that their average stock price is 16% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Charlie’s and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Charlie’s 0 0 0 0 N/A
Charlie’s Competitors 212 564 812 43 2.42

As a group, “Medicinals & botanicals” companies have a potential upside of 106.49%. Given Charlie’s’ rivals higher probable upside, analysts plainly believe Charlie’s has less favorable growth aspects than its rivals.


This table compares Charlie’s and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Charlie’s -6.02% -51.60% -17.95%
Charlie’s Competitors -11.70% -83.78% 22.26%

About Charlie’s

(Get Rating)

Charlies Holdings, Inc. engages in providing nicotine-only, e-cigarette and hemp-derived, CBD wellness liquid spaces through its subsidiary companies, Charlie’s Chalk Dust LLC and Don Polly LLC. It operates through the International and United States geographical segments. The company was founded by Brandon Stump and Ryan Stump in January 2001 and is headquartered in Costa Mesa, CA.

Receive News & Ratings for Charlie's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charlie's and related companies with MarketBeat.com's FREE daily email newsletter.